Busch M - Search Results

1

Identification of HIV-infected transfusion recipients: the utility of crossreferencing previous donor records with AIDS case reports.

Samson S, Busch M, Ward J, Garner J, Salk S, Fernando L, Holland P, Rutherford G, Benjamin R, Perkins H. Samson S, et al. Among authors: busch m. Transfusion. 1990 Mar-Apr;30(3):214-8. doi: 10.1046/j.1537-2995.1990.30390194339.x. Transfusion. 1990. PMID: 2315995

2

Post-transfusion hepatitis C virus infection.

Kleinman S, Busch M, Holland P. Kleinman S, et al. Among authors: busch m. N Engl J Med. 1992 Nov 26;327(22):1601-2. doi: 10.1056/NEJM199211263272216. N Engl J Med. 1992. PMID: 1279422 No abstract available.

3

Allogeneic leukocytes but not therapeutic blood elements induce reactivation and dissemination of latent human immunodeficiency virus type 1 infection: implications for transfusion support of infected patients.

Busch MP, Lee TH, Heitman J. Busch MP, et al. Blood. 1992 Oct 15;80(8):2128-35. Blood. 1992. PMID: 1391964 Free article.

4

Increased detection of hepatitis C virus (HCV)-infected blood donors by a multiple-antigen HCV enzyme immunoassay.

Kleinman S, Alter H, Busch M, Holland P, Tegtmeier G, Nelles M, Lee S, Page E, Wilber J, Polito A. Kleinman S, et al. Among authors: busch m. Transfusion. 1992 Nov-Dec;32(9):805-13. doi: 10.1046/j.1537-2995.1992.32993110750.x. Transfusion. 1992. PMID: 1471243

5

Epidemiologic background of blood donors with antibody to human T-cell lymphotropic virus. Transfusion Safety Study Group.

Operskalski EA, Schiff ER, Kleinman SH, Busch M, Taylor PE, Parks WP, Lee H, Tomasulo PA, Donegan E, Stuart M, et al. Operskalski EA, et al. Among authors: busch m. Transfusion. 1989 Oct;29(8):746-8. doi: 10.1046/j.1537-2995.1989.29890020448.x. Transfusion. 1989. PMID: 2572078

6

Duration of time from onset of human immunodeficiency virus type 1 infectiousness to development of detectable antibody. The HIV Seroconversion Study Group.

Petersen LR, Satten GA, Dodd R, Busch M, Kleinman S, Grindon A, Lenes B. Petersen LR, et al. Among authors: busch m. Transfusion. 1994 Apr;34(4):283-9. doi: 10.1046/j.1537-2995.1994.34494233574.x. Transfusion. 1994. PMID: 8178324

7

Quantitation of residual WBCs in filtered blood components by high-throughput, real-time kinetic PCR.

Lee TH, Wen L, Chrebtow V, Higuchi R, Watson RM, Sninsky JJ, Busch MP. Lee TH, et al. Among authors: busch mp. Transfusion. 2002 Jan;42(1):87-93. doi: 10.1046/j.1537-2995.2002.00009.x. Transfusion. 2002. PMID: 11896318

8

HIV seroconverting donors delay their return: screening test implications.

Schreiber GB, Glynn SA, Satten GA, Kong F, Wright D, Busch MP, Tu Y, Kleinman SH; Retrovirus Epidemiology Donor Study. Schreiber GB, et al. Transfusion. 2002 Apr;42(4):414-21. doi: 10.1046/j.1525-1438.2002.00084.x. Transfusion. 2002. PMID: 12076287

9

Absence of HBV and HCV, HTLV-I and -II, and human herpes virus-8 activation after allogeneic RBC transfusion in patients with advanced HIV-1 infection.

Asmuth DM, Kalish LA, Laycock ME, Murphy EL, Mohr BA, Lee TH, Gallarda J, Giachetti C, Dollard SC, van der Horst CM, Grant RM, Busch MP; Viral Activation Transfusion Study Group. Asmuth DM, et al. Among authors: busch mp. Transfusion. 2003 Apr;43(4):451-8. doi: 10.1046/j.1537-2995.2003.00350.x. Transfusion. 2003. PMID: 12662277 Clinical Trial.

10

Frequency and duration of plasma CMV viremia in seroconverting blood donors and recipients.

Drew WL, Tegtmeier G, Alter HJ, Laycock ME, Miner RC, Busch MP. Drew WL, et al. Transfusion. 2003 Mar;43(3):309-13. doi: 10.1046/j.1537-2995.2003.00337.x. Transfusion. 2003. PMID: 12675714

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,873 results

Search Page

Filters